Despite Big M&As, Life-Science Startups Aren't Too Lively These Days

Published: Jun 12, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The profusion of big mergers in pharmaceuticals, such as Valeant Pharmaceuticals International’s $54 billion offer for Allergan (AGN), creates the impression that the life-science sector is booming. But the pipeline of new companies is going dry, according to a new study. Hey, check out all the research scientist jobs. Post your resume today!

Back to news